Trial Profile
Comparison Between Monoclonal Antibody CD20 Treatment (Rituximab (mabthera))and General Corticotherapy Treatment in Patients With Pemphigus
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Corticosteroids
- Indications Pemphigus; Pemphigus vulgaris
- Focus Registrational; Therapeutic Use
- Acronyms Ritux 3; Rituximab 3
- 18 Mar 2020 Results of a post-hoc analysis published in the JAMA Dermatology
- 14 Dec 2019 Article focusing on the efficacy and safety/tolerability of rituximab in combination with a tapering course of corticosteroids in the treatment of adults with moderate to severe PV published in the American Journal of Clinical Dermatology
- 05 Sep 2019 Results of post-hoc analysis published in the British Journal of Dermatology.